Raiff Partners’s Pfizer PFE Stock Holding History

Raiff Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-36,890	Closed	-$1.23M	–	44
2016 Q2	$1.23M	Sell	36,890 -89,590	-71%	-$2.86M	3.55%	11
2016 Q1	$3.56M	Sell	126,480 -110,670	-47%	-$3.16M	4.04%	10
2015 Q4	$7.26M	Buy	237,150 +231,880	+4,400%	+$7.29M	10.86%	1
2015 Q3	$157K	Sell	5,270 -100,130	-95%	-$3.21M	0.46%	13
2015 Q2	$3.35M	Buy	+105,400	New	+$3.44M	3.66%	11
2015 Q1	–	Sell	-52,700	Closed	-$1.56M	–	50
2014 Q4	$1.56M	Buy	+52,700	New	+$1.51M	1.27%	26
2014 Q3	–	Sell	-247,690	Closed	-$6.97M	–	33
2014 Q2	$6.97M	Buy	+247,690	New	+$7.06M	5.05%	6
2014 Q1	–	Sell	-147,560	Closed	-$4.29M	–	41
2013 Q4	$4.29M	Buy	+147,560	New	+$4.29M	3.35%	13
2013 Q3	–	Sell	-263,500	Closed	-$7M	–	44
2013 Q2	$7M	Buy	+263,500	New	+$7.28M	5.2%	4

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Raiff Partners's PFE Position: Q3 2016 in Review

Raiff Partners sold out of Pfizer (PFE) in Q3 2016, closing a stake of 36,890 shares — an estimated $1.23M sold.

Raiff Partners first reported a position in PFE in Q2 2013 and held it in 9 quarters. The position peaked at $7.26M in Q4 2015. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Raiff Partners reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
Raiff Partners sold 36,890 Pfizer shares in Q3 2016, an estimated $1.23M.
Raiff Partners first reported a position in Pfizer in Q2 2013 and held it in 9 quarters.
Raiff Partners's Pfizer position peaked at $7.26M in Q4 2015.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Raiff Partners's 13F filing for Q3 2016, filed 14 Nov 2016.